Form 8-K WRIGHT MEDICAL GROUP For: Dec 30

�

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

�

�

FORM�8-K

�

�

CURRENT REPORT

Pursuant to Section�13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December�30, 2014

�

�

Wright Medical Group,�Inc.

(Exact Name of Registrant Specified in Charter)

�

�

�

Delaware	�	001-35823	�	13-4088127
(State or Other Jurisdiction of Incorporation)	�	(Commission File Number)	�	(I.R.S. Employer Identification No.)

�

1023 Cherry Road Memphis, Tennessee	�	38117
(Address of Principal Executive Offices)	�	(Zip Code)

Registrant�s telephone number, including area code: (901)�867-9971

�

�

Check the appropriate box below if the Form�8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

�

�

�

Written communications pursuant to Rule�425 under the Securities Act (17 CFR 230.425)

�

�

x

Soliciting material pursuant to Rule�14a-12 under the Exchange Act (17 CFR 240.14a-12)

�

�

�

Pre-commencement communications pursuant to Rule�14d-2(b)�under the Exchange Act (17 CFR 240.14d-2(b))

�

�

�

Pre-commencement communications pursuant to Rule�13e-4(c)�under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

---

Item�8.01.

Other Events.

On December�30, 2014, Wright Medical Group, Inc. announced that Tornier N.V. had voluntarily withdrawn and�refiled�its Hart-Scott-Rodino (�HSR�) notification and report form relating to the parties previously announced proposed merger. The withdrawal and refiling of the form provides the Federal Trade Commission with additional time to review the proposed transaction in the initial phase. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act is now scheduled to expire on Wednesday, January�28, 2015, at 11:59 p.m., New York City time, unless earlier terminated or a request for additional information or documentary materials is issued to either party prior to the expiration of the waiting period.

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

�

	�		�	WRIGHT MEDICAL GROUP,�INC.
Date: December�30, 2014	�		�	By:	�	/s/ Lance A. Berry
	�		�		�	Lance A. Berry
	�		�		�	Senior Vice President and Chief Financial Officer

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Northern Horizon Capital AS 2023 Annual Report
• Result of AGM
• InvoiceCloud's Exceptional Customer Service Recognized in the 2024 American Business Awards® and 2024 Stevie® Awards for Sales & Customer Service